Nursing  ||| S:0 E:8 ||| NN
actions  ||| S:8 E:16 ||| NNS
increases  ||| S:16 E:26 ||| VBZ
the  ||| S:26 E:30 ||| DT
control  ||| S:30 E:38 ||| NN
of  ||| S:38 E:41 ||| IN
hypertensive  ||| S:41 E:54 ||| JJ
patients  ||| S:54 E:63 ||| NNS
and  ||| S:63 E:67 ||| CC
reduces  ||| S:67 E:75 ||| VBZ
white-coat  ||| S:75 E:86 ||| JJ
effect  ||| S:86 E:93 ||| NN
A  ||| S:93 E:95 ||| DT
randomized  ||| S:95 E:106 ||| JJ
comparative  ||| S:106 E:118 ||| JJ
study  ||| S:118 E:124 ||| NN
was  ||| S:124 E:128 ||| VBD
performed  ||| S:128 E:138 ||| VBN
to  ||| S:138 E:141 ||| TO
evaluate  ||| S:141 E:150 ||| VB
the  ||| S:150 E:154 ||| DT
control  ||| S:154 E:162 ||| NN
of  ||| S:162 E:165 ||| IN
hypertension  ||| S:165 E:178 ||| NN
with  ||| S:178 E:183 ||| IN
use  ||| S:183 E:187 ||| NN
of  ||| S:187 E:190 ||| IN
home  ||| S:190 E:195 ||| NN
blood  ||| S:195 E:201 ||| NN
pressure  ||| S:201 E:210 ||| NN
measurement  ||| S:210 E:222 ||| NN
( ||| S:222 E:223 ||| -LRB-
HBPM ||| S:223 E:227 ||| NNP
)  ||| S:227 E:229 ||| -RRB-
and  ||| S:229 E:233 ||| CC
casual  ||| S:233 E:240 ||| JJ
blood  ||| S:240 E:246 ||| NN
pressure  ||| S:246 E:255 ||| NN
measurement ||| S:255 E:266 ||| NN
,  ||| S:266 E:268 ||| ,
and  ||| S:268 E:272 ||| CC
analyze  ||| S:272 E:280 ||| VB
the  ||| S:280 E:284 ||| DT
white  ||| S:284 E:290 ||| JJ
coat  ||| S:290 E:295 ||| NN
effect ||| S:295 E:301 ||| NN
.  ||| S:301 E:303 ||| .
Hypertensive  ||| S:303 E:316 ||| JJ
patients  ||| S:316 E:325 ||| NNS
in  ||| S:325 E:328 ||| IN
primary  ||| S:328 E:336 ||| JJ
health  ||| S:336 E:343 ||| NN
care  ||| S:343 E:348 ||| NN
units  ||| S:348 E:354 ||| NNS
were  ||| S:354 E:359 ||| VBD
randomly  ||| S:359 E:368 ||| RB
divided  ||| S:368 E:376 ||| VBN
into  ||| S:376 E:381 ||| IN
two  ||| S:381 E:385 ||| CD
groups ||| S:385 E:391 ||| NNS
:  ||| S:391 E:393 ||| :
group  ||| S:393 E:399 ||| NN
I ||| S:399 E:400 ||| PRP
,  ||| S:400 E:402 ||| ,
participating  ||| S:402 E:416 ||| VBG
of  ||| S:416 E:419 ||| IN
the  ||| S:419 E:423 ||| DT
educational  ||| S:423 E:435 ||| JJ
activities  ||| S:435 E:446 ||| NNS
and  ||| S:446 E:450 ||| CC
group  ||| S:450 E:456 ||| NN
II  ||| S:456 E:459 ||| NNP
that  ||| S:459 E:464 ||| WDT
followed  ||| S:464 E:473 ||| VBD
the  ||| S:473 E:477 ||| DT
routine  ||| S:477 E:485 ||| JJ
treatment ||| S:485 E:494 ||| NN
.  ||| S:494 E:496 ||| .
The  ||| S:496 E:500 ||| DT
hypertensive  ||| S:500 E:513 ||| JJ
patients  ||| S:513 E:522 ||| NNS
from  ||| S:522 E:527 ||| IN
group  ||| S:527 E:533 ||| NN
I  ||| S:533 E:535 ||| PRP
realized  ||| S:535 E:544 ||| VBD
HBPM  ||| S:544 E:549 ||| NNP
at  ||| S:549 E:552 ||| IN
the  ||| S:552 E:556 ||| DT
beginning  ||| S:556 E:566 ||| NN
and  ||| S:566 E:570 ||| CC
the  ||| S:570 E:574 ||| DT
end  ||| S:574 E:578 ||| NN
of  ||| S:578 E:581 ||| IN
the  ||| S:581 E:585 ||| DT
study ||| S:585 E:590 ||| NN
.  ||| S:590 E:592 ||| .
White-coat  ||| S:592 E:603 ||| JJ
effect  ||| S:603 E:610 ||| NN
was  ||| S:610 E:614 ||| VBD
evaluated  ||| S:614 E:624 ||| VBN
by  ||| S:624 E:627 ||| IN
the  ||| S:627 E:631 ||| DT
difference  ||| S:631 E:642 ||| NN
between  ||| S:642 E:650 ||| IN
the  ||| S:650 E:654 ||| DT
casual  ||| S:654 E:661 ||| JJ
blood  ||| S:661 E:667 ||| NN
pressure  ||| S:667 E:676 ||| NN
measurement  ||| S:676 E:688 ||| NN
and  ||| S:688 E:692 ||| CC
HBPM ||| S:692 E:696 ||| NNP
.  ||| S:696 E:698 ||| .
The  ||| S:698 E:702 ||| DT
study  ||| S:702 E:708 ||| NN
included  ||| S:708 E:717 ||| VBD
290  ||| S:717 E:721 ||| CD
hypertensive  ||| S:721 E:734 ||| CD
patients ||| S:734 E:742 ||| NNS
,  ||| S:742 E:744 ||| ,
but  ||| S:744 E:748 ||| CC
realized  ||| S:748 E:757 ||| VBD
HBPM  ||| S:757 E:762 ||| NNP
82  ||| S:762 E:765 ||| CD
hypertensive  ||| S:765 E:778 ||| CD
patients ||| S:778 E:786 ||| NNS
.  ||| S:786 E:788 ||| .
There  ||| S:788 E:794 ||| EX
was  ||| S:794 E:798 ||| VBD
increase  ||| S:798 E:807 ||| NN
in  ||| S:807 E:810 ||| IN
blood  ||| S:810 E:816 ||| NN
pressure  ||| S:816 E:825 ||| NN
control  ||| S:825 E:833 ||| NN
from  ||| S:833 E:838 ||| IN
the  ||| S:838 E:842 ||| DT
beginning  ||| S:842 E:852 ||| NN
to  ||| S:852 E:855 ||| TO
end  ||| S:855 E:859 ||| VB
of  ||| S:859 E:862 ||| IN
study  ||| S:862 E:868 ||| NN
in  ||| S:868 E:871 ||| IN
hypertensive  ||| S:871 E:884 ||| JJ
patients  ||| S:884 E:893 ||| NNS
from  ||| S:893 E:898 ||| IN
group  ||| S:898 E:904 ||| NN
I  ||| S:904 E:906 ||| PRP
( ||| S:906 E:907 ||| -LRB-
p  ||| S:907 E:909 ||| CD
< ||| S:909 E:911 ||| SYM
0.05 ||| S:911 E:915 ||| CD
)  ||| S:915 E:917 ||| -RRB-
measured  ||| S:917 E:926 ||| VBN
by  ||| S:926 E:929 ||| IN
HBP  ||| S:929 E:933 ||| NNP
( ||| S:933 E:934 ||| -LRB-
60 ||| S:934 E:936 ||| CD
%  ||| S:936 E:938 ||| NN
to  ||| S:938 E:941 ||| TO
68.3 ||| S:941 E:945 ||| CD
% ||| S:945 E:946 ||| NN
)  ||| S:946 E:948 ||| -RRB-
and  ||| S:948 E:952 ||| CC
casual  ||| S:952 E:959 ||| JJ
measurement  ||| S:959 E:971 ||| NN
( ||| S:971 E:972 ||| -LRB-
62 ||| S:972 E:974 ||| CD
%  ||| S:974 E:976 ||| NN
to  ||| S:976 E:979 ||| TO
71 ||| S:979 E:981 ||| CD
% ||| S:981 E:982 ||| NN
)  ||| S:982 E:984 ||| -RRB-
and  ||| S:984 E:988 ||| CC
in  ||| S:988 E:991 ||| IN
group  ||| S:991 E:997 ||| NN
II ||| S:997 E:999 ||| NNP
,  ||| S:999 E:1001 ||| ,
HMBP  ||| S:1001 E:1006 ||| NNP
hypertension  ||| S:1006 E:1019 ||| NN
control  ||| S:1019 E:1027 ||| NN
was  ||| S:1027 E:1031 ||| VBD
higher  ||| S:1031 E:1038 ||| JJR
than  ||| S:1038 E:1043 ||| IN
the  ||| S:1043 E:1047 ||| DT
casual  ||| S:1047 E:1054 ||| JJ
blood  ||| S:1054 E:1060 ||| NN
pressure  ||| S:1060 E:1069 ||| NN
measurement  ||| S:1069 E:1081 ||| NN
( ||| S:1081 E:1082 ||| -LRB-
63 ||| S:1082 E:1084 ||| CD
%  ||| S:1084 E:1086 ||| NN
vs  ||| S:1086 E:1089 ||| VBD
50 ||| S:1089 E:1091 ||| CD
% ||| S:1091 E:1092 ||| NN
) ||| S:1092 E:1093 ||| -RRB-
.  ||| S:1093 E:1095 ||| .
The  ||| S:1095 E:1099 ||| DT
white  ||| S:1099 E:1105 ||| JJ
coat  ||| S:1105 E:1110 ||| NN
effect  ||| S:1110 E:1117 ||| NN
was  ||| S:1117 E:1121 ||| VBD
greater  ||| S:1121 E:1129 ||| JJR
in  ||| S:1129 E:1132 ||| IN
hipertensive  ||| S:1132 E:1145 ||| JJ
patients  ||| S:1145 E:1154 ||| NNS
from  ||| S:1154 E:1159 ||| IN
group  ||| S:1159 E:1165 ||| NN
II ||| S:1165 E:1167 ||| NNP
.  ||| S:1167 E:1169 ||| .
